Search Results - "Salvia, R"

Insect antimicrobial peptides: potential weapons to counteract the antibiotic resistance by Manniello, M. D., Moretta, A., Salvia, R., Scieuzo, C., Lucchetti, D., Vogel, H., Sgambato, A., Falabella, P.

“…Misuse and overuse of antibiotics have contributed in the last decades to a phenomenon known as antibiotic resistance which is currently considered one of the…”
Get full text

Evolving management of pancreatic cystic neoplasms by Salvia, R., Marchegiani, G.

Get full text

Perioperative outcomes and long‐term quality of life after total pancreatectomy by Pulvirenti, A., Pea, A., Rezaee, N., Gasparini, C., Malleo, G., Weiss, M. J., Cameron, J. L., Wolfgang, C. L., He, J., Salvia, R.

“…Background Total pancreatectomy is required to treat diseases involving the entire pancreas, and is characterized by high morbidity rates and impaired…”
Get full text

Robotic versus laparoscopic distal pancreatectomy: multicentre analysis by Lof, S, van der Heijde, N, Abuawwad, M, Al-Sarireh, B, Boggi, U, Butturini, G, Capretti, G, Coratti, A, Casadei, R, D’Hondt, M, Esposito, A, Ferrari, G, Fusai, G, Giardino, A, Groot Koerkamp, B, Hackert, T, Kamarajah, S, Kauffmann, E F, Keck, T, Marudanayagam, R, Nickel, F, Manzoni, A, Pessaux, P, Pietrabissa, A, Rosso, E, Salvia, R, Soonawalla, Z, White, S, Zerbi, A, Besselink, M G, Abu Hilal, M

“…Abstract Background The role of minimally invasive distal pancreatectomy is still unclear, and whether robotic distal pancreatectomy (RDP) offers benefits over…”
Get full text

Concomitant Serous Cystadenoma and Intraductal Papillary Mucinous Neoplasm in Pancreatic Cysts—a Diagnostic and Surgical Dilemma by Pollini, T., Salvia, R., Maker, A.V.

Get full text

The prognostic impact of para-aortic lymph node metastasis in pancreatic cancer: A systematic review and meta-analysis by Paiella, S, Sandini, M, Gianotti, L, Butturini, G, Salvia, R, Bassi, C

“…Abstract Purpose To evaluate by a meta-analytic approach the long-term prognostic impact of para-aortic lymph node (PALN) involvement in resected ductal…”
Get full text

Actual malignancy risk of either operated or non-operated presumed mucinous cystic neoplasms of the pancreas under surveillance by Marchegiani, G, Andrianello, S, Crippa, S, Pollini, T, Belfiori, G, Gozzini, L, Cassalia, F, Caravati, A, Luchini, C, Doglioni, C, Bassi, C, Falconi, M, Salvia, R

“…Despite the low malignant potential of pancreatic mucinous cystic neoplasms (MCNs), surgery is still performed. The aim of this pragmatic study was to assess…”
Get full text

Feasibility and safety of radiofrequency ablation for locally advanced pancreatic cancer by Girelli, R., Frigerio, I., Salvia, R., Barbi, E., Tinazzi Martini, P., Bassi, C.

“…Background: Radiofrequency ablation (RFA) may be a valuable treatment option for locally advanced pancreatic cancer. The present study examined its feasibility…”
Get full text

Importance of main pancreatic duct dilatation in IPMN undergoing surveillance by Marchegiani, G., Andrianello, S., Morbin, G., Secchettin, E., D'Onofrio, M., De Robertis, R., Malleo, G., Bassi, C., Salvia, R.

“…Background The association between risk of pancreatic cancer and a dilated main pancreatic duct (MPD) in intraductal papillary mucinous neoplasm (IPMN) is…”
Get full text

Intraoperative blood loss estimation in hepato-pancreato-biliary surgery: relevant, not reported, not standardized. Results from a systematic review and a worldwide snapshot survey by Perri, Giampaolo, Marchegiani, G., Reich, F., Salvia, R., Bassi, C.

Get full text

FAM49B, a novel regulator of mitochondrial function and integrity that suppresses tumor metastasis by Chattaragada, M S, Riganti, C, Sassoe, M, Principe, M, Santamorena, M M, Roux, C, Curcio, C, Evangelista, A, Allavena, P, Salvia, R, Rusev, B, Scarpa, A, Cappello, P, Novelli, F

“…Mitochondrial dysregulation plays a central role in cancers and drives reactive oxygen species (ROS)-dependent tumor progression. We investigated the…”
Get full text

Use of an intraoperative wound protector to prevent surgical‐site infection after pancreatoduodenectomy: randomized clinical trial by De Pastena, M., Marchegiani, G., Paiella, S., Fontana, M., Esposito, A., Casetti, L., Secchettin, E., Manzini, G., Bassi, C., Salvia, R.

“…Background Surgical‐site infection (SSI) increases treatment costs, duration of hospital stay and readmission rate after pancreatic surgery. This study aimed…”
Get full text

Pancreatic insufficiency after different resections for benign tumours by Falconi, M., Mantovani, W., Crippa, S., Mascetta, G., Salvia, R., Pederzoli, P.

“…Background: Pancreatic resections for benign diseases may lead to long‐term endocrine/exocrine impairment. The aim of this study was to compare postoperative…”
Get full text

Systematic review and meta-analysis of observational studies on BD-IPMNS progression to malignancy by Balduzzi, A., Marchegiani, G., Pollini, T., Biancotto, M., Caravati, A., Stigliani, E., Burelli, A., Bassi, C., Salvia, R.

“…The vast majority of presumed branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) of the pancreas are referred to a surveillance program due to the…”
Get full text

Postoperative serum hyperamylasemia (POH) adds value to the Fistula Risk Score (FRS) in predicting pancreatic fistula after pancreatoduodenectomy by Bannone, Elisa, Perri, G., Peressotti, S., Corvino, G., Marchetti, A., Bassi, C., Salvia, R.

Get full text

Routes of nutrition for Pancreatic Fistula after Pancreatoduodenectomy: A prospective snapshot study identifies the need for therapy standardization by Romandini, Elisa, Perri, G., Marchegiani, G., Cattelani, A., Corvino, G., Bassi, C., Salvia, R.

Get full text

Progression from biochemical leak to pancreatic fistula after distal pancreatectomy. Don't cry over spilt amylase by Ciprani, D, Bannone, E, Marchegiani, G, Nessi, C, Salvia, R, Bassi, C

“…BackgroundPostoperative pancreatic fistula (POPF) is a frequent complication after distal pancreatectomy (DP), but its upgrading from biochemical leak (BL)…”
Get full text

High-risk pancreatic anastomosis vs. total pancreatectomy after pancreatoduodenectomy by Perri, G., Marchegiani, G., Burelli, A., Bassi, C., Salvia, R.

Get full text

FOLFIRINOX or Gemcitabine-based Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: A Multi-institutional, Patient-Level, Meta-analysis and Systematic Review by Eshmuminov, Dilmurodjon, Aminjonov, Botirjon, Palm, Russell F., Malleo, Giuseppe, Schmocker, Ryan K., Abdallah, Raëf, Yoo, Changhoon, Shaib, Walid L., Schneider, Marcel André, Rangelova, Elena, Choi, Yoo Jin, Kim, Hongbeom, Rose, J. Bart, Patel, Sameer, Wilson, Gregory C., Maloney, Sarah, Timmermann, Lea, Sahora, Klaus, Rössler, Fabian, Lopez-Lopez, Víctor, Boyer, Emanuel, Maggino, Laura, Malinka, Thomas, Park, Jeong Youp, Katz, Matthew H. G., Prakash, Laura, Ahmad, Syed A., Helton, Scott, Jang, Jin-Young, Hoffe, Sarah E., Salvia, Roberto, Taieb, Julien, He, Jin, Clavien, Pierre-Alain, Held, Ulrike, Lehmann, Kuno

“…Background Pancreatic cancer often presents as locally advanced (LAPC) or borderline resectable (BRPC). Neoadjuvant systemic therapy is recommended as initial…”
Get full text

Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study by Moekotte, A L, Malleo, G, van Roessel, S, Bonds, M, Halimi, A, Zarantonello, L, Napoli, N, Dreyer, S B, Wellner, U F, Bolm, L, Mavroeidis, V K, Robinson, S, Khalil, K, Ferraro, D, Mortimer, M C, Harris, S, Al-Sarireh, B, Fusai, G K, Roberts, K J, Fontana, M, White, S A, Soonawalla, Z, Jamieson, N B, Boggi, U, Alseidi, A, Shablak, A, Wilmink, J W, Primrose, J N, Salvia, R, Bassi, C, Besselink, M G, Abu Hilal, M

“…Abstract Background Whether patients who undergo resection of ampullary adenocarcinoma have a survival benefit from adjuvant chemotherapy is currently unknown…”
Get full text